Meta Health Limited
Meta Health Limited
Meta Health Limited (META), formerly known as Metal Component Engineering Limited, was founded in 1987 in Singapore. With consistent focus on quality and engineering innovation, META has expanded its customer base by serving MNC (Multi-National-Corporation), EMS (Electronic Manufacturing Services), and SME (Small-Medium-Enterprise) globally.
META has recently diversified into healthcare technology and services with investment into Gainhealth Pte. Ltd., a direct-to-consumer and high-growth omnichannel health and wellness platform. Their healthcare segments now include (1) Primary & Homecare, (2) Central Pharmacy, (3) Clinical Nutrition distribution and (4) Infrastructure as a service (where they help medical institutes digitalise their operations)
FY2022 Results Announcement
15 Feb 2023
-
8 Aug 2023
-
8 Aug 2023
-
3 Aug 2023
-
3 Aug 2023
-
16 Jun 2023
-
31 May 2023
-
30 May 2023
-
24 May 23
-
30 Apr 23
-
25 Apr 23
-
14 Apr 23
-
14 Apr 23
-
14 Apr 23
-
14 Apr 23
-
14 Apr 23
-
12 Apr 23
-
28 Feb 23
-
31 Jan 23
-
13 Jan 23
-
10 Jan 23
-
21 Dec 22
-
4 Nov 22
-
26 Sep 22
-
19 Aug 22
-
19 Aug 22
-
18 Aug 22
-
17 Aug 22
Proxy to the digitalization of healthcare in the region
- Central Pharmacy facilitates the delivery of medicine for likes of clinics and nursing homes to end patients
- Rising user base for E-pharmacy
- Provides platform for medical institutes looking to digitalise their operations under the IAAS segment
Clinical Nutrition Distribution to tap into the central pharmacy’s B2B network for distribution
- Distributing to over 600 repeat customers including retailers and F&B outlets, Meta Health’s distribution arm has room for further growth as it taps into its central pharmacy’s network for cross-selling opportunities
Infrastructure-as-a-service (IAAS) segment can be highly scalable and profitable
- in collaboration with other vendors including MedTel, Meta Health has successfully launched a comprehensive suite of software solutions to help medical institutes digitalise their operations without incurring heavy CAPE
Price | 0.0390 |
---|---|
Market Cap (SGDm) | 20.5M |
YE | 31 Dec 21 |
Free Float % | 97.2% |
Key Highlights | 2020 | 2021 |
---|---|---|
Revenue (SGD m) | 32.2 | 43.0 |
Net Profit | (2.0) | 7.6 |
Adjusted net Profit/(Loss) to Owners | (2.o) | (1.6)* |
Net Asset Value | 15.3 | 23.0 |
Net Cash/(Debt) | (1.5) | 4.7 |